Instruments

Name Stock exchange Average volume Price Type
NAITO & CO., LTD. 7624

Japan Exchange

32,667 148 JPY Stock Naito & Co., Ltd. Stock

News (418)

Biogen : “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea PU
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status AQ
Transcript : Eisai Co., Ltd., 2024 Earnings Call, May 15, 2024
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status GL
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status PR
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA PR
Transcript : Eisai Co., Ltd. - Special Call
Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected RE
EISAI INVESTS IN C2N TO SUPPORT SIMPLIFYING THE DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE TO BETTER SERVE PATIENT AQ
"LEQEMBI Intravenous Infusion"Lecanemab) for the Treatment of Alzheimer's Disease to be Launched in Japan on December 20 AQ
Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20 RE
Transcript : Eisai Co., Ltd. - Special Call
Biogen : “LEQEMBI® Intravenous Infusion” (Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20 PU
Transcript : Eisai Co., Ltd., Q2 2024 Earnings Call, Nov 07, 2023
EISAI PRESENTS NEW LEQEMBI INVESTIGATIONAL SUBCUTANEOUS FORMULATION INTERIM STUDY RESULTS AND CLINICAL IMPROVEMENT DATA IN EARLIER STAGES OF EARLY ALZHEIMER'S DISEASE FROM ADDITIONAL ANALYSES OF CLARITY AD AQ
Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer’s Disease From Additional Analyses of Clarity AD at The Clinical Trials On Alzheimer’s Disease (CTAD) Conference GL
EISAI PRESENTS NEW LEQEMBI® (LECANEMAB-IRMB) INVESTIGATIONAL SUBCUTANEOUS FORMULATION INTERIM STUDY RESULTS AND CLINICAL IMPROVEMENT DATA IN EARLIER STAGES OF EARLY ALZHEIMER'S DISEASE FROM ADDITIONAL ANALYSES OF CLARITY AD AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE PR
Eisai : Latest Value Creation Report PU
Eisai Co., Ltd. - LEQEMBI Intravenous Infusion Approved for the Treatment of Alzheimer's disease in Japan AQ
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen AQ
"LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan AQ
UPDATE2: Japan approves Alzheimer's drug developed by Eisai, Biogen AQ
LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan GL
Eisai Presents Latest Analysis of Lecanemab's Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer's Association International Conference (AAIC) 2023 PR
Eisai Presents Latest Analysis of Lecanemab’s Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer’s Association International Conference (AAIC) 2023 GL
Eisai exec who helped steer Alzheimer's drug approval to leave RE
Eisai exec who helped steer Alzheimer's drug approval to retire in July RE
EISAI - FDA GRANTS TRADITIONAL APPROVAL FOR LEQEMBI FOR THE TREATMENT OF ALZHEIMER'S DISEASE AQ
UPDATE4: U.S. formally approves Alzheimer's drug developed by Japan's Eisai AQ
UPDATE3: U.S. formally approves Alzheimer's drug developed by Japan's Eisai AQ
Transcript : Eisai Co., Ltd. - Special Call
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease GL
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease AQ
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer's Disease PR
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease AQ
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease GL
Biogen : EISAI FILES MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER’S DISEASE IN SOUTH KOREA PU
Biogen : EISAI SUBMITS MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER’S DISEASE IN GREAT BRITAIN PU
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease GL
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease AQ
Transcript : Eisai Co., Ltd., 2023 Earnings Call, May 15, 2023
Eisai : and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 Trials of LENVIMA® (lenvatinib) Plus KEYTRUDA® (pembrolizumab) in Certain Patients With Advanced Melanoma (LEAP-003) and Metastatic Colorectal Cancer (LEAP-017) PU
ADDITIONAL DETAILED ANALYSES FROM PHASE 2 STUDY 201 OF LECANEMAB PUBLISHED AS THREE PAPERS IN PEER-REVIEWED JOURNALS PR
EISAI PRESENTED NEW ANALYSES OF ARIA AND QOL ON LECANEMAB IN CLARITY AD AT THE AD/PD™ 2023 ANNUAL MEETING PR
Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD/PD™ 2023 Annual Meeting GL
1234NextSee all

Companies (1)

NAITO & CO., LTD. 51 M $
Logo Naito & Co., Ltd.

Naito & Co Ltd is a Japan-based company mainly engaged in the sale of cutting tools, measurement, industrial equipment, machine tools and others. Cutting tools include drilling and chamfering tools, threading tools, milling tools, turning tools, and cutti ...


Insiders


Picture Haruo Naito
Haruo Naito

Haruo Naito holds the position of Chief Executive Officer & Representative Director at Eisai Co., Ltd. and Chairman at The Naito Foundation. Mr. Naito is also Chairman for The Naito Foundation.


Picture Hiroyasu Naito
Hiroyasu Naito

Presently, Hiroyasu Naito holds the position of Executive President & Representative Director at Rinnai Corp. He is also on the board of Nagoya Railroad Co., Ltd.


Picture Tadaaki Naito
Tadaaki Naito

Presently, Tadaaki Naito holds the position of Chairman of Nippon Yusen KK. Mr. Naito is also on the board of Mitsubishi Logistics Corp. and World Shipping Council. Mr. Naito received an undergraduate degree from the University of Hitotsubashi.


Picture Keisuke Naito
Keisuke Naito

Keisuke Naito has worked at Eisai Co., Ltd.
since 2013.
His current position is SVP, Chief Strategy, Planning & Ecosystem Officer.


Picture Shunichi Naito
Shunichi Naito

Shunichi Naito is currently the President of Suntory Business Expert Ltd.
He previously held the position of Senior Managing Director at Suntory Spirits Ltd.
(Old) and Co-Chief Operating Officer, Director & EVP at Suntory Holdings Ltd.


Picture Takaya Naito
Takaya Naito

Takaya Naito worked at Toyo Engineering Corp.
from 2012 to 2018, where he held the position of Director in 2018.


Picture Akio Naito
Akio Naito

Akio Naito is currently an Outside Director at Seiko Instruments, Inc. since 2013.
He is also a Director & Senior Managing Executive Officer at Seiko Group Corp.
since 1984.
Additionally, he holds the position of Director at Seiko Optical Products Co., Ltd.
since 2012 and Outside Director at Seiko Time Systems, Inc. since 2012.
Furthermore, he serves as a Director & Senior Executive Vice President at Seiko Watch Corp.
since 2016.
Mr. Naito is also a Director at the Japanese Chamber of Commerce & Industry of New York, Inc. In his former positions, Mr. Naito served as Chairman, President & Chief Executive Officer at Seiko Corporation of America.
He was also an Outside Director at Ohara, Inc. and a Director at Seiko Solutions, Inc.


Picture Kazuhiro Naito
Kazuhiro Naito

Mr. Kazuhiro Naito is Executive Officer & Head-Stainless Valve Business at KITZ Corp., Chairman at Kitz Corporation of Kunshan Co. Ltd., and Chairman at Kitz Corporation of Taiwan.








Picture Toshihiro Naito
Toshihiro Naito

Toshihiro Naito has worked at Intertrade Co., Ltd.
since 2013.
His current position is Director & General Manager-Healthcare, which he started in 2019.


Picture Hideo Naito
Hideo Naito

Hideo Naito is the founder of Shin Maint Holdings Co., Ltd., which was founded in 1985.
He currently holds the position of Chairman & President at Shin Maint Holdings Co., Ltd.
Additionally, Mr. Naito is currently the Chairman at Tesco Co. Ltd.
(Tokyo) since 2017, the Director at Shumanagement KK since 2007, and the President & Representative Director at Shin Pro Maint, Inc. since 2017.



Picture Masakazu Naito
Masakazu Naito

Masakazu Naito has worked at Teraoka Seisakusho Co., Ltd.
since 2009.
His current position is MD, Head-Corporate Planning & Quality Assurance, which he started in 2018.


Picture Kazumi Naito
Kazumi Naito

Kazumi Naito currently works at Parker Corp., as Director & Managing Executive Officer from 2020 and Heisei Corp.
KK, as President & Representative Director from 2020.


Picture Shinichiro Naito
Shinichiro Naito

Shinichiro Naito currently works at Data Horizon Co., Ltd., as Director & General Manager-Administration from 2020, Data Horizon Phils, Inc., as Director from 2008, and DPP Health Partners Co., Ltd., as Managing Director from 2017.


Picture Satoshi Naito
Satoshi Naito

Satoshi Naito has worked at Wakamoto Pharmaceutical Co., Ltd.
since 1982.
His current position is Executive Officer & Manager-Pharmaceutical Affairs, which he started in 2019.


Picture Kazuakira Naito
Kazuakira Naito

Kazuakira Naito is currently the Chairman of Yamagata Bar Association, Director of Japan Federation of Bar Associations, Director of Tohoku Federation of Bar Associations, and Non-Executive Director of Yamagata Prefectural University of Health Sciences.
Previously, he served as an Independent Outside Director at Jimoto Holdings, Inc.








Picture Masayoshi Naito
Masayoshi Naito

Masayoshi Naito is currently a Director at MRK Holdings, Inc., Wonder Corp., Shonan Bellmare KK, B&D Co., Ltd., Vidaway KK, Auntie Rosa Co., Ltd., D&M Co., Ltd.
(Japan), and REXT, Inc. He is also the President & Representative Director at Onko, Inc. and a Senior Executive Officer & GM-Purchasing at RIZAP GROUP, Inc. In the past, he held positions as a Director at Jeans Mate Corp., GORIN Packing Co., Ltd., and Misuzu Co., Ltd.




Picture Noboru Naito
Noboru Naito

Noboru Naito worked at KOSÉ Corp.
for over 40 years, starting in 1977 and ending in 2018.
He held the position of Managing Director in 2017-2018.



Picture Shohei Naito
Shohei Naito

Shohei Naito currently works at The Japan Institute of International Affairs, as Member.
Mr. Naito also formerly worked at Umicore SA, as Independent Non-Executive Director from 2010 to 2014.
Mr. Naito received his graduate degree from the University of Tokyo.




Picture Makio Naito
Makio Naito

Makio Naito is currently an Outside Director at Toyo Tanso Co., Ltd.
since 2023 and a Professor at Osaka University since 2005.
Previously, he worked as a Deputy Manager at Japan Fine Ceramics Center from 1993 to 2002 and as a Director at Hosokawa Micron Corp.


Picture Masayuki Naito
Masayuki Naito

Masayuki Naito worked as a Director & Manager-Overseas Business Promotion at Chino Corp.
from 1973 to 2011.




Picture Masaaki Naito
Masaaki Naito

Masaaki Naito currently works at Shinwa Co., Ltd., as Independent Outside Director from 2015 and The Tono Shinkin Bank, as Auditor from 2006.
Mr. Naito received his graduate degree in 1984 from the University of Tokyo.


Picture Isao Naito
Isao Naito

Isao Naito has held various director positions in multiple companies, including Artnature, Inc., Artnature (Shanghai), Inc., Artnature Singapore Pte Ltd., Artnature Malaysia Sdn.
Bhd., ARTNATURE (Thailand) Co. Ltd., and NAO-ART Corp.

















Picture Mitsuru Naito
Mitsuru Naito

Mitsuru Naito currently works as a Director & Corporate Manager at TSI Holdings Co., Ltd.



Picture Kurano Naito
Kurano Naito

Kurano Naito has worked at Hamayuu Co., Ltd.
since 1978.
He currently holds the position of Director & Products Manager, which he started in 2008.





Picture Tetsuya Naito
Tetsuya Naito

Tetsuya Naito currently works at The Yamanashi Chuo Bank, Ltd., as Executive Officer & Manager-Corporate Planning.






Picture Ryo Naito
Ryo Naito

Ryo Naito is the founder of Paraca, Inc., a company founded in 1997, where he holds the title of Chairman & President.
He is currently working as a Director at Kamiyacho Park YK since 2009.
Mr. Naito completed his undergraduate degree at Hiroshima University.




Picture Tomoki Naito
Tomoki Naito

Tomoki Naito currently works at Shin-Keisei Electric Railway Co., Ltd., as Head-Finance & Accounting.


Picture Yoshihiro Naito
Yoshihiro Naito

Yoshihiro Naito currently works at The Ashikaga Bank Ltd., as Director & Managing Executive Officer from 2020 and Mebuki Financial Group, Inc., as Director & Manager-Business Administration from 2020.



Picture Toshio Naito
Toshio Naito

Toshio Naito is currently a Director & Executive Officer at KOKUYO CO., LTD.


Picture Tatuya Naito
Tatuya Naito

Tatuya Naito currently works at Fujisoft DIS Co. Ltd., as Auditor.


Picture Yoko Naito
Yoko Naito

Yoko Naito has a current job as an Outside Director at freee K.K.


Picture Yu Naito
Yu Naito

Yu Naito currently works as an Auditor Manager at Soda Nikka Co., Ltd.



Picture Takayasu Naito
Takayasu Naito

Takayasu Naito is currently the President & Representative Director at Shizuoka Gas Living KK.




Picture Naoki Naito
Naoki Naito

Naoki Naito currently works at Foodison, Inc., as CFO, Director & Manager-Corporate Administration from 2018.
Mr. Naito received his Masters Business Admin degree from The Wharton School of the University of Pennsylvania and undergraduate degree from School of Education Waseda University.






Picture Tsuneo Naito
Tsuneo Naito

Tsuneo Naito currently works at Kyodo Printing Co., Ltd., as Independent Outside Non-Executive Director from 2016.












No results for this search